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Recently, compelling evidence reveals that stromal
populations, especially the fibroblastic reticular cells
(FRC), of the secondary lymphoid organs (SLO) not
only serve as structure scaffold for organizing and main-
taining the structure of the lymphoid tissues, but also
possess crucial functions in immune regulation, includ-
ing induction of T cell tolerance and the generation of
regulator T cells. Interestingly, we and others recently
reported that similar lymphoid-like fibroblastic reticular
cells also exist within the tumor microenvironment
(TME) that facilitates the organization of tumors, as
well as the induction of immune tolerance. We showed
that those stromal cells augmented the differentiation of
myeloid cells, including myeloid derived suppressors
(MDSCs). As chronic inflammation plays a vital role in
tumor initiation, progression, and metastases, we hypothe-
sized that the crucial functions of these lymphoid-like
FRCs in the TME are to induce immunotolerance and
promote chronic inflammation, thereby promoting tumor
progression. In this study, we examined the cellular and
molecular characteristics of these FRCs and revealed their
heterogeneity both at cellular and molecular levels. Inter-
estingly, some of their properties appear to be intrinsic,
not easily altered by the milieu they reside. Functionally,
these FRCs provide crucial signals for the survival, differ-
entiation, and tolerogenic phenotype of myeloid cells,
including MDSC, dendritic cells, and macrophages. We
are currently in the process of elucidating the molecular
mechanism by which these FRCs induce tolerogenic
myeloid populations. Our better understanding of the
immune modulatory function and specific mechanisms of
these FRCs, both within the lymphoid tissues and TME,
will provide valuable information for the development of
novel immunotherapy regimens to improve therapeutic
outcome by combining active immunotherapy and the
ultimate reversal of tumor-induced immunotolerance.
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